109 related articles for article (PubMed ID: 38850807)
1. Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis.
Mazzotta C; Ingelfinger JR; Grabowski EF
Thromb Res; 2024 May; 240():109038. PubMed ID: 38850807
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor.
Lo NC; Turner NA; Cruz MA; Moake J
J Biol Chem; 2013 Nov; 288(46):33118-23. PubMed ID: 24097977
[TBL] [Abstract][Full Text] [Related]
5. Platelet thrombus formation in eHUS is prevented by anti-MBL2.
Kushak RI; Boyle DC; Rosales IA; Ingelfinger JR; Stahl GL; Ozaki M; Colvin RB; Grabowski EF
PLoS One; 2019; 14(12):e0220483. PubMed ID: 31881024
[TBL] [Abstract][Full Text] [Related]
6. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a spontaneously transformed human endothelial cell line.
Cockerill GW; Meyer G; Noack L; Vadas MA; Gamble JR
Lab Invest; 1994 Oct; 71(4):497-509. PubMed ID: 7526034
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
Liu F; Huang J; Sadler JE
Blood; 2011 Sep; 118(12):3392-8. PubMed ID: 21816831
[TBL] [Abstract][Full Text] [Related]
9. Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression.
Nestoridi E; Kushak RI; Tsukurov O; Grabowski EF; Ingelfinger JR
Pediatr Nephrol; 2008 Feb; 23(2):221-31. PubMed ID: 18060435
[TBL] [Abstract][Full Text] [Related]
10. Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome.
Siegler RL; Pysher TJ; Tesh VL; Taylor FB
J Am Soc Nephrol; 2001 Jul; 12(7):1458-1467. PubMed ID: 11423574
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
Pysher TJ; Siegler RL; Tesh VL; Taylor FB
Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
[TBL] [Abstract][Full Text] [Related]
12. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1.
Zoja C; Angioletti S; Donadelli R; Zanchi C; Tomasoni S; Binda E; Imberti B; te Loo M; Monnens L; Remuzzi G; Morigi M
Kidney Int; 2002 Sep; 62(3):846-56. PubMed ID: 12164866
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.
Landoni VI; Pittaluga JR; Carestia A; Castillo LA; Nebel MC; Martire-Greco D; Birnberg-Weiss F; Schattner M; Schierloh P; Fernández GC
Front Cell Infect Microbiol; 2022; 12():897019. PubMed ID: 35811684
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
Ray PE; Liu XH
Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells.
Dong F; Zhao X; Wang J; Huang X; Li X; Zhang L; Dong H; Liu F; Fan M
Fundam Clin Pharmacol; 2021 Apr; 35(2):321-330. PubMed ID: 33107067
[TBL] [Abstract][Full Text] [Related]
16. Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation.
McLaughlin F; Ludbrook VJ; Cox J; von Carlowitz I; Brown S; Randi AM
Blood; 2001 Dec; 98(12):3332-9. PubMed ID: 11719371
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.
Huang J; Motto DG; Bundle DR; Sadler JE
Blood; 2010 Nov; 116(18):3653-9. PubMed ID: 20644116
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
[TBL] [Abstract][Full Text] [Related]
19. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
[TBL] [Abstract][Full Text] [Related]
20. Modeling Shiga toxin-induced human renal-specific microvascular injury.
Whelan R; Lih D; Xue J; Himmelfarb J; Zheng Y
Integr Biol (Camb); 2024 Jan; 16():. PubMed ID: 38266067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
